Teva Pharmaceutical Industries Limited
TEVANext catalyst
TEV-56248
Asthma
Get an email about TEVA's next catalysts
Track Teva Pharmaceutical Industries (TEVA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 7 more upcoming events in our data (Phase 3 readout, earnings, Phase 2 readout and more).See the timeline
8 upcoming, 1 past
TEV-56248 Phase 3 Est. Readout
Primary completion for TEV-56248 trial (NCT06052267) in Asthma
SourceFp/ABS Phase 3 Est. Readout
Primary completion for Fp/ABS trial (NCT06664619) in Asthma
SourceTEVA Earnings Report
EPS Est: $0.70 | FQ end Sep/2026 | Call: bmo
DTIC Phase 2 Est. Readout
Estimated primary completion for DTIC trial (NCT03755804) in Hodgkin Lymphoma. Topline data typically follows completion by weeks to months.
SourceFDA PDUFA Date ecopipam (priority review)
For Pediatric Tourette Syndrome. NDA filing. AI-extracted from news: U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-
SourceDeutetrabenazine Phase 3 Est. Readout
Estimated primary completion for Deutetrabenazine trial (NCT04713982) in Huntington Disease. Topline data typically follows completion by weeks to months.
Sourcerasagiline mesylate Patent Expiration
Key patent expires in 495 days. Potential generic competition.
TEV-56286 Phase 2 Est. Readout (TOPAS-MSA)
Primary completion for TEV-56286 trial (NCT06568237) in Multiple System Atrophy
SourceMarket Overview
Stock performance and key metrics
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
WebsiteProAir HFA inhaler
Asthma
BDP Nasal Aerosol
Allergic Rhinitis
Prednisone capsules
Perennial Allergic Rhinitis
Beclomethasone dipropionate breath-actuated inhaler
Persistent Asthma
Beclomethasone dipropionate via BAI
Persistent Asthma
DR-103
Pregnancy Prevention
Generic Budesonide/Formoterol Fumarate Dihydrate
Asthma
DR-1021
Healthy
TEV-50717
Cerebral Palsy, Dyskinetic
Tapinarof
Plaque Type Psorisis
Trifarotene Topical
Acne Vulgaris
Proventil® HFA
Asthma
Neugranin
Chemotherapy-induced Neutropenia
non-pegylated liposomal doxorubicin
Tubular Breast Cancer Stage II
Generic Estradiol Vaginal Cream USP
Atrophic Vaginitis
Glatiramer acetate (GA)
Relapsing Remitting Multiple Sclerosis
TV-46000
Schizophrenia
Reslizumab
Eosinophilic Asthma
TV-46763
Pain
lipegfilgrastim
Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
Generic Ivermectin Lotion
Head Lice
Fasinumab
Osteoarthritis, Knee
Kariva®
Healthy
Oral Corticosteroid (OCS)
Asthma
Glatiramer Acetate (DB)
Multiple Sclerosis
Fp/ABS
Asthma
Experimental Glatiramer Acetate
Relapsing Remitting Multiple Sclerosis
Glatiramer Acetate (OL)
Multiple Sclerosis
Chemotherapy Regimen
Chemotherapy-induced Neutropenia
Budesonide/Formoterol SPIROMAX®
Asthma
Albuterol Sulfate
Asthma
Fluticasone Propionate/Salmeterol
Asthma
Albuterol
Asthma
Deutetrabenazine
Huntington Disease
Laquinimod
Multiple Sclerosis
Albuterol MDPI
Asthma
Fluticasone propionate pressurized metered dose inhaler
Asthma
DR-102
Contraception
Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX
Asthma
Albuterol/salbutamol
Asthma
albuterol aerosol by HFA MDI
Exercise-induced Bronchospasm
Non-Oral Corticosteroid (non-OCS) Asthma Medication
Asthma
Albuterol Spiromax
Exercise-Induced Bronchoconstriction (EIB)
Fremanezumab
Migraine
Albuterol Spiromax®
Asthma
Albuterol sulfate (ABS)
Chronic Obstructive Pulmonary Disease
Albuterol/salmeterol HFA MDI
Asthma
Beclomethasone dipropionate
Seasonal Allergic Rhinitis
albuterol/salbutamol HFA
Persistent Asthma
Diclofenac sodium
Actinic Keratosis
Glatiramer Acetate
Relapsing Remitting Multiple Sclerosis
FS MDPI
Asthma
SD-809
Chorea
Fp MDPI
Persistent Asthma
Estradiol
Dyspareunia
BDP HFA
Seasonal Allergic Rhinitis
ACR16
Huntington Disease
Beclomethasone dipropionate BAI
Asthma
Fluticasone Propionate and Salmeterol Inhalation Powder
Asthma
Beclomethasone Dipropionate 640
Persistent Asthma
BDP
Allergic Rhinitis
Oxymetazoline Hydrochloride
Rosacea
Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol
Rhinitis, Allergic, Perennial
beclomethasone dipropionate (QVAR)
Asthma
Bendamustine hydrochloride
Non-Hodgkin Lymphoma
rasagiline mesylate
Multiple System Atrophy
GA 20 mg/mL
Relapsing-Remitting Multiple Sclerosis
Hydrocodone ER
Low Back Pain
Imiquimod
Actinic Keratosis
TEV-56248
Asthma
TV-44749
Schizophrenia
Balugrastim
Chemotherapy-induced Neutropenia
laquinimod 0.6
Relapsing Remitting Multiple Sclerosis
SPIRIVA® HandiHaler®
COPD
DTIC
Hodgkin Lymphoma
Nebulized IVX-0142
Asthma
laquinimod 0.3
Relapsing Remitting Multiple Sclerosis
Tizanidine (sublingual or oral)
Muscle Spasticity
TEV-53408
Celiac Disease
CEP-18770
Multiple Myeloma
desogestrel/ethinyl estradiol and ethinyl estradiol
Hemostasis
TV-1380
Cocaine Addiction
Beclomethasone dipropionate HFA Nasal Aerosol
Seasonal Allergic Rhinitis
Mometasone furoate
Seasonal Allergic Rhinitis
Fentanyl Buccal Tablet
Advanced Cancers
Arsenic Trioxide
Lung Cancer
BeEAM
Multiple Myeloma
Omacetaxine
Leukemia
tbo-filgrastim
Neutropenia
TEV-56286
Multiple System Atrophy
Tiotropium HFA BAI
COPD
TEV-48574 Dose Regimen A
Crohn Disease
etiprednol dicloacetate
Crohn's Disease
talampanel
Dyskinesias
Omacetaxine mepesuccinate
Chronic Myeloid Leukemia
91-day Levonorgestrel Oral Contraceptive
Hemostasis
TV-45070
Postherpetic Neuralgia
ProAir HFA
Asthma
Glatiramer Acetate, N-Acetylcysteine
Relapse Remitting Multiple Sclerosis
Rasagiline
Dementia
Flovent Diskus
Asthma
LBR-101 High Dose
Chronic Migraine
glatiramer acetate with minocycline
Relapse Remitting Multiple Sclerosis
Advair Diskus
Asthma
TP-38
Recurrent Glioblastoma Multiforme
glatiramer acetate, with mitoxantrone
Relapsing Remitting Multiple Sclerosis
Bronchodilator
Asthma
LBR-101 Low Dose
Episodic Migraine Headache
temozolomide(TMZ)
Glioblastoma Multiforme
TEV-48574
Crohn Disease
TV-1106
Growth Hormone Deficiency
Delayed Release 6MP or Calcitriol vs. Purinethol
Crohn's Disease
ProAir® HFA
Asthma
TEV-48574 Dose Regiment B
Crohn Disease
TP38
Recurrent Glioblastoma Multiforme
Immediate release morphine
Cancer
Albuterol HFA-BOI
Asthma
Armodafinil
Stroke
Beclomethasone dipropionate HFA
Asthma
Prednisolone/Prednisone
Lupus Nephritis
adjuvant TMZ
Glioblastoma Multiforme
Spiriva® Respimat®
COPD
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ProAir HFA inhaler | Phase 3 | Asthma | - | - |
BDP Nasal Aerosol | Phase 3 | Allergic Rhinitis | - | - |
Prednisone capsules | Phase 3 | Perennial Allergic Rhinitis | - | - |
Beclomethasone dipropionate breath-actuated inhaler | Phase 3 | Persistent Asthma | - | - |
Beclomethasone dipropionate via BAI | Phase 3 | Persistent Asthma | - | - |
DR-103 | Phase 3 | Pregnancy Prevention | - | - |
Generic Budesonide/Formoterol Fumarate Dihydrate | Phase 3 | Asthma | - | - |
DR-1021 | Phase 3 | Healthy | - | - |
TEV-50717 | Phase 3 | Cerebral Palsy, Dyskinetic | - | - |
Tapinarof | Phase 3 | Plaque Type Psorisis | - | - |
Trifarotene Topical | Phase 3 | Acne Vulgaris | - | - |
Proventil® HFA | Phase 3 | Asthma | - | - |
Neugranin | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
non-pegylated liposomal doxorubicin | Phase 3 | Tubular Breast Cancer Stage II | - | - |
Generic Estradiol Vaginal Cream USP | Phase 3 | Atrophic Vaginitis | - | - |
Glatiramer acetate (GA) | Phase 3 | Relapsing Remitting Multiple Sclerosis | - | - |
TV-46000 | Phase 3 | Schizophrenia | - | - |
Reslizumab | Phase 3 | Eosinophilic Asthma | - | - |
TV-46763 | Phase 3 | Pain | - | - |
lipegfilgrastim | Phase 3 | Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia | - | - |
Generic Ivermectin Lotion | Phase 3 | Head Lice | - | - |
Fasinumab | Phase 3 | Osteoarthritis, Knee | - | - |
Kariva® | Phase 3 | Healthy | - | - |
Oral Corticosteroid (OCS) | Phase 3 | Asthma | - | - |
Glatiramer Acetate (DB) | Phase 3 | Multiple Sclerosis | - | - |
Fp/ABS | Phase 3 | Asthma | - | - |
Experimental Glatiramer Acetate | Phase 3 | Relapsing Remitting Multiple Sclerosis | - | - |
Glatiramer Acetate (OL) | Phase 3 | Multiple Sclerosis | - | - |
Chemotherapy Regimen | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
Budesonide/Formoterol SPIROMAX® | Phase 3 | Asthma | - | - |
Albuterol Sulfate | Phase 3 | Asthma | - | - |
Fluticasone Propionate/Salmeterol | Phase 3 | Asthma | - | - |
Albuterol | Phase 3 | Asthma | - | - |
Deutetrabenazine | Phase 3 | Huntington Disease | - | - |
Laquinimod | Phase 3 | Multiple Sclerosis | - | - |
Albuterol MDPI | Phase 3 | Asthma | - | - |
Fluticasone propionate pressurized metered dose inhaler | Phase 3 | Asthma | - | - |
DR-102 | Phase 3 | Contraception | - | - |
Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX | Phase 3 | Asthma | - | - |
Albuterol/salbutamol | Phase 3 | Asthma | - | - |
albuterol aerosol by HFA MDI | Phase 3 | Exercise-induced Bronchospasm | - | - |
Non-Oral Corticosteroid (non-OCS) Asthma Medication | Phase 3 | Asthma | - | - |
Albuterol Spiromax | Phase 3 | Exercise-Induced Bronchoconstriction (EIB) | - | - |
Fremanezumab | Phase 3 | Migraine | - | - |
Albuterol Spiromax® | Phase 3 | Asthma | - | - |
Albuterol sulfate (ABS) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Albuterol/salmeterol HFA MDI | Phase 3 | Asthma | - | - |
Beclomethasone dipropionate | Phase 3 | Seasonal Allergic Rhinitis | - | - |
albuterol/salbutamol HFA | Phase 3 | Persistent Asthma | - | - |
Diclofenac sodium | Phase 3 | Actinic Keratosis | - | - |
Glatiramer Acetate | Phase 3 | Relapsing Remitting Multiple Sclerosis | - | |
FS MDPI | Phase 3 | Asthma | - | - |
SD-809 | Phase 3 | Chorea | - | - |
Fp MDPI | Phase 3 | Persistent Asthma | - | - |
Estradiol | Phase 3 | Dyspareunia | - | - |
BDP HFA | Phase 3 | Seasonal Allergic Rhinitis | - | - |
ACR16 | Phase 3 | Huntington Disease | - | - |
Beclomethasone dipropionate BAI | Phase 3 | Asthma | - | - |
Fluticasone Propionate and Salmeterol Inhalation Powder | Phase 3 | Asthma | - | - |
Beclomethasone Dipropionate 640 | Phase 3 | Persistent Asthma | - | - |
BDP | Phase 3 | Allergic Rhinitis | - | - |
Oxymetazoline Hydrochloride | Phase 3 | Rosacea | - | - |
Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol | Phase 3 | Rhinitis, Allergic, Perennial | - | - |
beclomethasone dipropionate (QVAR) | Phase 3 | Asthma | - | - |
Bendamustine hydrochloride | Phase 3 | Non-Hodgkin Lymphoma | - | - |
rasagiline mesylate | Phase 3 | Multiple System Atrophy | - | Patent 2027 |
GA 20 mg/mL | Phase 3 | Relapsing-Remitting Multiple Sclerosis | - | - |
Hydrocodone ER | Phase 3 | Low Back Pain | - | - |
Imiquimod | Phase 3 | Actinic Keratosis | - | - |
TEV-56248 | Phase 3 | Asthma | - | - |
TV-44749 | Phase 3 | Schizophrenia | - | - |
Balugrastim | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
laquinimod 0.6 | Phase 2 | Relapsing Remitting Multiple Sclerosis | - | - |
SPIRIVA® HandiHaler® | Phase 2 | COPD | - | - |
DTIC | Phase 2 | Hodgkin Lymphoma | - | - |
Nebulized IVX-0142 | Phase 2 | Asthma | - | - |
laquinimod 0.3 | Phase 2 | Relapsing Remitting Multiple Sclerosis | - | - |
Tizanidine (sublingual or oral) | Phase 2 | Muscle Spasticity | - | - |
TEV-53408 | Phase 2 | Celiac Disease | - | - |
CEP-18770 | Phase 2 | Multiple Myeloma | - | - |
desogestrel/ethinyl estradiol and ethinyl estradiol | Phase 2 | Hemostasis | - | - |
TV-1380 | Phase 2 | Cocaine Addiction | - | - |
Beclomethasone dipropionate HFA Nasal Aerosol | Phase 2 | Seasonal Allergic Rhinitis | - | - |
Mometasone furoate | Phase 2 | Seasonal Allergic Rhinitis | - | - |
Fentanyl Buccal Tablet | Phase 2 | Advanced Cancers | - | - |
Arsenic Trioxide | Phase 2 | Lung Cancer | - | - |
BeEAM | Phase 2 | Multiple Myeloma | - | - |
Omacetaxine | Phase 2 | Leukemia | - | - |
tbo-filgrastim | Phase 2 | Neutropenia | - | - |
TEV-56286 | Phase 2 | Multiple System Atrophy | - | - |
Tiotropium HFA BAI | Phase 2 | COPD | - | - |
TEV-48574 Dose Regimen A | Phase 2 | Crohn Disease | - | - |
etiprednol dicloacetate | Phase 2 | Crohn's Disease | - | - |
talampanel | Phase 2 | Dyskinesias | - | - |
Omacetaxine mepesuccinate | Phase 2 | Chronic Myeloid Leukemia | - | - |
91-day Levonorgestrel Oral Contraceptive | Phase 2 | Hemostasis | - | - |
TV-45070 | Phase 2 | Postherpetic Neuralgia | - | - |
ProAir HFA | Phase 2 | Asthma | - | - |
Glatiramer Acetate, N-Acetylcysteine | Phase 2 | Relapse Remitting Multiple Sclerosis | - | - |
Rasagiline | Phase 2 | Dementia | - | - |
Flovent Diskus | Phase 2 | Asthma | - | - |
LBR-101 High Dose | Phase 2 | Chronic Migraine | - | - |
glatiramer acetate with minocycline | Phase 2 | Relapse Remitting Multiple Sclerosis | - | - |
Advair Diskus | Phase 2 | Asthma | - | - |
TP-38 | Phase 2 | Recurrent Glioblastoma Multiforme | - | - |
glatiramer acetate, with mitoxantrone | Phase 2 | Relapsing Remitting Multiple Sclerosis | - | - |
Bronchodilator | Phase 2 | Asthma | - | - |
LBR-101 Low Dose | Phase 2 | Episodic Migraine Headache | - | - |
temozolomide(TMZ) | Phase 2 | Glioblastoma Multiforme | - | - |
TEV-48574 | Phase 2 | Crohn Disease | - | - |
TV-1106 | Phase 2 | Growth Hormone Deficiency | - | - |
Delayed Release 6MP or Calcitriol vs. Purinethol | Phase 2 | Crohn's Disease | - | - |
ProAir® HFA | Phase 2 | Asthma | - | - |
TEV-48574 Dose Regiment B | Phase 2 | Crohn Disease | - | - |
TP38 | Phase 2 | Recurrent Glioblastoma Multiforme | - | - |
Immediate release morphine | Phase 2 | Cancer | - | - |
Albuterol HFA-BOI | Phase 2 | Asthma | - | - |
Armodafinil | Phase 2 | Stroke | - | - |
Beclomethasone dipropionate HFA | Phase 2 | Asthma | - | - |
Prednisolone/Prednisone | Phase 2 | Lupus Nephritis | - | - |
adjuvant TMZ | Phase 2 | Glioblastoma Multiforme | - | - |
Spiriva® Respimat® | Phase 2 | COPD | - | - |
Schizophrenia
3 drugs in this indication
Multiple Sclerosis
2 drugs in this indication
Schizophrenia in adults
2 drugs in this indication
Eye disease (Eylea biosimilar)
1 drug in this indication
asthma
1 drug in this indication
Pediatric patients with Tourette Syndrome
1 drug in this indication
Parkinson's Disease
1 drug in this indication
Amyotrophic Lateral Sclerosis
1 drug in this indication
Tourette syndrome in pediatric patients
1 drug in this indication
agitation
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Teva Pharmaceutical Industries Limited's drug pipeline?→
CatalystAlert tracks 122 drug candidates in Teva Pharmaceutical Industries Limited's (TEVA) pipeline across Phase 3, Phase 2. Its lead program is Deutetrabenazine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Teva Pharmaceutical Industries Limited's next FDA catalyst?→
Teva Pharmaceutical Industries Limited's (TEVA) next tracked catalyst is a Phase 3 readout expected October 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TEVA biotech catalysts?→
Add TEVA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Teva Pharmaceutical Industries Limited's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.